Cytokine Storm: The Unmet Need Sigyn Hopes To Address
The company has developed a device for extracorporeal blood filtration that is compatible with dialysis machines.
You may also be interested in...
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.
Start-up Esper Bionics has designed a prosthetic hand that can anticipate a user’s actions, changing the game for amputees.